A study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered with a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants

Trial Identifier: 214099
Sponsor: GlaxoSmithKline
Collaborator:
PPD Development LP
Start Date: December 2022
Primary Completion Date: October 2023
Study Completion Date: October 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
UNITED_STATES, FL Orlando, FL, UNITED_STATES, 32806
UNITED_STATES, NV Las Vegas, NV, UNITED_STATES, 89113
UNITED_STATES, TX Austin, TX, UNITED_STATES, 78744